BRPI0600799B8 - composição farmacêutica contendo em associação ubidecarenona, dexpantenol e cloro-hexidina ou seu sal farmaceuticamente aceitável para aplicação cutânea, seu processo de preparação e usos - Google Patents
composição farmacêutica contendo em associação ubidecarenona, dexpantenol e cloro-hexidina ou seu sal farmaceuticamente aceitável para aplicação cutânea, seu processo de preparação e usosInfo
- Publication number
- BRPI0600799B8 BRPI0600799B8 BRPI0600799A BRPI0600799B8 BR PI0600799 B8 BRPI0600799 B8 BR PI0600799B8 BR PI0600799 A BRPI0600799 A BR PI0600799A BR PI0600799 B8 BRPI0600799 B8 BR PI0600799B8
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- ubidecarenone
- dexpanthenol
- chlorhexidine
- association
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 title abstract 2
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 title abstract 2
- 239000011703 D-panthenol Substances 0.000 title abstract 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 title abstract 2
- 235000004866 D-panthenol Nutrition 0.000 title abstract 2
- 229960003260 chlorhexidine Drugs 0.000 title abstract 2
- 235000017471 coenzyme Q10 Nutrition 0.000 title abstract 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 title abstract 2
- 229960003949 dexpanthenol Drugs 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title abstract 2
- 229960004747 ubidecarenone Drugs 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title 1
- 239000000126 substance Substances 0.000 abstract 3
- 208000016583 Anus disease Diseases 0.000 abstract 2
- 206010002153 Anal fissure Diseases 0.000 abstract 1
- 208000009531 Fissure in Ano Diseases 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 230000002421 anti-septic effect Effects 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 239000000645 desinfectant Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Dispersion Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05398003A EP1700597B1 (en) | 2005-03-04 | 2005-03-04 | Pharmaceutical composition containing in association ubidecarenone, dexpanthenol and chlorhexidine or a pharmaceutically acceptable salt thereof for cutaneous application |
| EP05398003.3 | 2005-03-04 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0600799A BRPI0600799A (pt) | 2007-05-15 |
| BRPI0600799B1 BRPI0600799B1 (pt) | 2019-07-23 |
| BRPI0600799B8 true BRPI0600799B8 (pt) | 2021-05-25 |
Family
ID=35601798
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0600799-6 BRPI0600799B8 (pt) | 2005-03-04 | 2006-03-06 | composição farmacêutica contendo em associação ubidecarenona, dexpantenol e cloro-hexidina ou seu sal farmaceuticamente aceitável para aplicação cutânea, seu processo de preparação e usos |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1700597B1 (pt) |
| AT (1) | ATE458477T1 (pt) |
| BR (1) | BRPI0600799B8 (pt) |
| DE (1) | DE602005019533D1 (pt) |
| ES (1) | ES2341784T3 (pt) |
| MA (1) | MA28210A1 (pt) |
| PL (1) | PL1700597T3 (pt) |
| PT (1) | PT1700597E (pt) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002004004A1 (en) * | 2000-07-11 | 2002-01-17 | Collaborative Technologies, Inc. | Methods for preparing high pressure/high shear dispersions containing waxes and other semi-solidds and oils |
| CN1470236A (zh) * | 2002-07-26 | 2004-01-28 | 武汉市第四医院 | 一种治疗痔疮和肛裂的多组分制剂 |
| WO2005018530A2 (en) * | 2003-08-25 | 2005-03-03 | Foamix Ltd. | Penetrating pharmaceutical foam |
-
2005
- 2005-03-04 EP EP05398003A patent/EP1700597B1/en not_active Expired - Lifetime
- 2005-03-04 AT AT05398003T patent/ATE458477T1/de not_active IP Right Cessation
- 2005-03-04 ES ES05398003T patent/ES2341784T3/es not_active Expired - Lifetime
- 2005-03-04 PL PL05398003T patent/PL1700597T3/pl unknown
- 2005-03-04 DE DE602005019533T patent/DE602005019533D1/de not_active Expired - Lifetime
- 2005-03-04 PT PT05398003T patent/PT1700597E/pt unknown
-
2006
- 2006-03-03 MA MA28854A patent/MA28210A1/fr unknown
- 2006-03-06 BR BRPI0600799-6 patent/BRPI0600799B8/pt active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| PT1700597E (pt) | 2010-06-01 |
| ES2341784T3 (es) | 2010-06-28 |
| EP1700597A1 (en) | 2006-09-13 |
| PL1700597T3 (pl) | 2010-07-30 |
| DE602005019533D1 (de) | 2010-04-08 |
| EP1700597B1 (en) | 2010-02-24 |
| ATE458477T1 (de) | 2010-03-15 |
| BRPI0600799A (pt) | 2007-05-15 |
| BRPI0600799B1 (pt) | 2019-07-23 |
| MA28210A1 (fr) | 2006-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0508540A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BR112015029491A2 (pt) | derivados de imidazopirrolidinona e seu uso no tratamento de doença | |
| AR058679A1 (es) | Preparacion farmaceutica que contiene meloxicam | |
| BR112012009376A2 (pt) | composição farmacêutica, forma de dosagem farmacêutica, processo para a sua preparação, métodos de tratamento e seu uso | |
| DE60313597D1 (de) | Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis | |
| BRPI0717367B8 (pt) | di-hidropirazolonas substituídas, seus usos e seu processo de preparação, e medicamento | |
| BRPI0507755A (pt) | composto de pirazolina substituìda, processo para a sua manufatura, medicamentos e seus usos | |
| PA8657201A1 (es) | Compuestos de 3h-oxazolo y 3h-tiazolo [4, 5-d] pirimidin-2-ona 3, 5-disustituida y 3, 5, 7 - trisustituida y profarmacos de los mismos | |
| CY1108794T1 (el) | Σπειροκυκλικα παραγωγα κυκλοεξανιου | |
| BR112012006010A2 (pt) | composto de glicina | |
| ECSP066608A (es) | Suspensiones acuosas de ciclesonide para nebulización | |
| BRPI1010861A8 (pt) | métodos para tratamento de dor, inflamação ou osteoartrite, pacote e formulação farmacêutica | |
| BRPI0908432A2 (pt) | composições antimicrobianas tópicas | |
| BR0313718A (pt) | Composto, processo para a preparação do mesmo, composição farmacêutica, métodos para tratar um indivìduo humano ou animal sofrendo de uma condição que é mediada por cox-2 e para tratar um indivìduo humano ou animal sofrendo de um distúrbio inflamatório, e, uso de um composto | |
| BR112012030641A2 (pt) | métodos e composições para terapia farmacêutica oral | |
| AR049518A1 (es) | Composicion farmaceutica que comprende un agente siliconado y dos principios activos solubilizados | |
| BRPI0519280A2 (pt) | composto, composiÇço farmacÊutica e uso de um composto | |
| EA200601846A1 (ru) | Содержащие бензоксазины лекарственные комбинации для лечения заболеваний дыхательных путей | |
| WO2004100893A3 (en) | Methods for treatment of inflammatory diseases using ct-3 or analogs thereof | |
| MX2009004692A (es) | Composicion para el tratamiento de afecciones de la piel. | |
| BR112014002885A2 (pt) | uso de composto orgânico para o tratamento da síndrome de noonan | |
| BR0116653A (pt) | Medicamento contendo uma poliamina como substância ativa | |
| BR112014027213A8 (pt) | nova composição de alfentanil para o tratamento de dor aguda | |
| BRPI0715609A2 (pt) | Composto, uso de um composto, métodos para produzir um efeito antiproliferativo em um animal de sangue quente, e para tratar uma doença em um animal de sangue quente, e, composição farmacêutica | |
| BRPI0600799B8 (pt) | composição farmacêutica contendo em associação ubidecarenona, dexpantenol e cloro-hexidina ou seu sal farmaceuticamente aceitável para aplicação cutânea, seu processo de preparação e usos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 23/07/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 23/07/2019, OBSERVADAS AS CONDICOES LEGAIS |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/03/2006 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |